Healthcare

Impressive Results Continue from CytoDyn’s (OTC: CYDY) Clinical Trials Evaluating Two Patients with Leronlimab, One in mTNBC and One in MBC

VANCOUVER, Washington, Jan 22, 2020 — First patient with metastatic triple-negative breast cancer (mTNBC) continues to show no detectable circulating tumor cells (CTC) or putative metastatic tumor cells after 15 weeks of treatment with leronlimab […]

Healthcare

CytoDyn (OTC: CYDY) Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab for the Treatment of Metastatic Triple-Negative Breast Cancer

VANCOUVER, Washington, Jan. 13, 2020  — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the […]

Consumer

Nightfood (OTC: NGTF) Continues Hotel Expansion, Will Exhibit at the Hotel Supply Show of the Southeast

Nightfood sleep-friendly ice cream in hotel freezers can deliver better-for-you snacking benefits to road-weary travelers Tarrytown, NY –  January 06, 2020 – Nightfood, Inc. (OTCQB: NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar […]

Healthcare

CytoDyn (OTC: CYDY) Reports Early, But Strong Positive Clinical Responses for Two Patients, One in Metastatic Breast Cancer and One in Metastatic Triple-Negative Breast Cancer Trials

Objective clinical responses in these two patients treated with leronlimab (PRO 140) lead to plans for imminent filing of a Breakthrough Therapy Designation Application while trial enrollment efforts continue at much higher pace VANCOUVER, Washington, […]

Healthcare

CytoDyn (OTC: CYDY) Signs Definitive Agreements with Vyera Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV

VANCOUVER, Washington and NEW YORK, Dec 17, 2019 – In exchange for the exclusive right to market and distribute leronlimab in the U.S. for HIV-related indications, Vyera will pay upfront and regulatory and sales-based milestone […]

Consumer

Nightfood (OTC: NGTF)/Harris Poll Study Shows 54% of U.S. Consumers Who Snack at Night Often Feel Guilty About Their Nighttime Snack Choices; Nightfood Management Estimates Over Seven Hundred Million Nighttime Snack Occasions Weekly

TARRYTOWN, NY, Dec 17, 2019 (otcqb:NGTF),83% of consumers report snacking at least one night a week, and 20% of consumers report snacking every night via NEWMEDIAWIRE — Nightfood, Inc. (otcqb:NGTF), the award-winning ice cream company […]

Newsmakers

NexTech’s (OTC: NEXCF) Industry-Leading WebAR Solution Adopted by Major Firearms Distributor Davidson’s Inc

NEW YORK and TORONTO, Dec. 13, 2019 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality (AR) for eCommerce and AR learning applications is pleased to announce Davidson’s Inc., one of the largest American […]

Healthcare

CytoDyn (OTC: CYDY) to Hold Investment Community Conference Call on December 17, 2019

VANCOUVER, Washington, Dec. 11, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Nader […]